QQ客服 官方微博 反馈留言

	Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis
	Wu Mei-Ping[1]; Zhang Yi-Shuai[2]; Xu Xiangbin[3]; Zhou Qian[4]; Li Jian-Dong[5]; Yan Chen[6]
刊名	Cardiovascular drugs and therapy
	2017
卷号	31页码:157-166
关键词	Cardiac fibrosis Cardiac hypertrophy Cardiac remodeling PDE1 Vinpocetine
ISSN号	1573-7241
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2224152
专题	上海大学
作者单位	1.Department of Cardiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China. 2.Aab Cardiovascular Research Institute, School of Medicine and Dentistry, University of Rochester, 601 Elmwood Ave, Box CVRI, Rochester, NY, 14642, USA. 3.Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 14642, USA. 4.Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30302, USA. jdli@gsu.edu.
推荐引用方式 GB/T 7714	Wu Mei-Ping[1],Zhang Yi-Shuai[2],Xu Xiangbin[3],et al. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis[J]. Cardiovascular drugs and therapy,2017,31:157-166.
APA	Wu Mei-Ping[1],Zhang Yi-Shuai[2],Xu Xiangbin[3],Zhou Qian[4],Li Jian-Dong[5],&Yan Chen[6].(2017).Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.Cardiovascular drugs and therapy,31,157-166.
MLA	Wu Mei-Ping[1],et al."Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis".Cardiovascular drugs and therapy 31(2017):157-166.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。